In Depth 12 Oct 2023 Can immunometabolism-based therapies transform the way cancers and autoimmune diseases are treated? …modify metabolic pathways, does it not almost automatically manifest as a more toxic effect on the individual?” Weir explained that they intend to address this by choosing the right target…. October 12, 2023 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Interview 13 Jun 2018 CAR-T Brings Hope for Cancer Patients, But Challenges Lie Ahead …in the blood vessels that feed tumors, triggering the CAR-T cell to kill the cancer cell or blood vessels. “The first asset we have is a very broad asset, it’s… June 13, 2018 - 5 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
In Depth 5 Feb 2024 Future of cancer treatment: what will therapy look like in 2034? …it comes to tailoring patient-specific drugs. Echoing these thoughts, Catherine Pickering, said: “We know that some people respond better to targeted therapies depending on the genetic profile of their tumor,… February 5, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 27 Jun 2024 The 2024 drug approval list: Eight new treatments you should know about …healthy cells. But it hasn’t been smooth sailing for telomerase inhibitors – the class of drugs that imetelstat belongs to – which was once poised to be a “magic bullet”… June 27, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 23 Sep 2025 Navigating German biotech: 14 key players to know …that many cancers overproduce to keep immune cells out of the tumor microenvironment. By blocking this signal, CatalYm’s antibody visugromab is designed to open the door for T cells to… September 23, 2025 - 16 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 16 Apr 2025 HIV innovation: Six companies developing new treatments in 2025 …IMC-M113V binds to these infected cells, it brings in T cells to kill them. The goal is to shrink the pool of infected cells that remain in the body even… April 16, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Sponsored by WuXi Advanced Therapies 17 Jan 2023 Navigating cell and gene therapy manufacturing with a long-term partnership …therapy is getting the gene to the right place and remaining there for the right amount of time – that’s just the efficacy part,” explains Chang. “But we don’t want… January 17, 2023 - 7 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
In Depth 30 Oct 2024 Spatial Transcriptomics: A window into disease …are there, but where the immune cell types are, what immune cells are present, and are they actually invading the tumor or not,” said Richard Terry, founder of tech company… October 30, 2024 - 11 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 8 Jun 2018 People with Innate Resistance to HIV Could Provide a Functional HIV Cure …a TCR immunotherapy that could benefit HIV infected patients,” said Chakrabarti. “The idea would be to harvest patient T cells, to transfer a public TCR to these T cells, and… June 8, 2018 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 17 May 2023 Six Norwegian companies leading the country’s biotech scene …the site of the tumor. The mechanism behind CyPep-1 is to inject the therapy into the tumor to target the tumor cells. CyPep-1, which is positively charged, binds to the… May 17, 2023 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 31 Oct 2024 Halloween biotech stories: Unveiling scientists’ worst fears …government regulations… Beyond the typical mad scientist scenario, accidents can happen too – what if a grand-scale revolutionary treatment to cure cancer turned out to eradicate mankind? That is what… October 31, 2024 - 15 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 2 Dec 2022 Creating designer immune cells at scale …the targeted immune cells. Also, the iPSCs do not need to be replaced until around three months down the line to keep quality consistent. Immune cells on a large scale… December 2, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email